Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (websockets) API Google Sheets add-on Excel add-on
Community
Academy 134 articles Forum Github 13 repos
Marketplace
Spreadsheets
Google Sheets add-on Excel add-on Wordpress plugin
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. NASDAQ /
  3. ASND.NASDAQ

Ascendis Pharma AS (ASND NASDAQ) stock market data APIs

$135.48 1.73(1.3%) as of July 26, 2024
Price chart is built with Anychart

Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapies for unmet medical needs. It offers SKYTROFA for treating patients with growth hormone deficiency (GHD). The company is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark.

Ascendis Pharma AS Financial Data Overview

133.75
135.48
-
136.36
132.99
85.285-161
7 741 M
57 138 K
329 M
-2.3
0.632
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'ASND',
Type: 'Common Stock',
Name: 'Ascendis Pharma AS',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG007R7VNC1',
ISIN: NULL,
CUSIP: NULL,
CIK: NULL,
EmployerIdNumber: '',
FiscalYearEnd: 'December',
IPODate: '2015-01-28',
InternationalDomestic: 'Domestic',
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'ADR',
IsDelisted: false,
}

Ascendis Pharma AS Fundamental Data is available in our Financial Data APIs

  • Net Revenue 329 M
  • EBITDA -354 516 992
  • Earnings Per Share -9.62
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Ascendis Pharma AS Earnings via APIs

  • Latest Release 2024-05-02
  • EPS/Forecast -1.5

Get Ascendis Pharma AS End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Ascendis Pharma AS latest news via APIs

Despite shrinking by US$346m in the past week, Ascendis Pharma (NASDAQ:ASND) shareholders are still up 54% over 1 year

Passive investing in index funds can generate returns that roughly match the overall market. But you can significantly boost your returns by picking above-average stocks. For example, the Ascendis Pha...

2 Biotech Stocks With Big FDA Decisions Approaching – Here’s What Analysts Expect

There are few sectors that can offer investors massive returns – but biotech comes to mind as one. These companies are typically involved in the pharmaceutical or medical device industries, and they...
Do you have any questions?
support@eodhistoricaldata.com